Effects of Recombinant Leukemia Inhibitory Factor (LIF) on Functional Status of Mouse Embryonic Stem Cells by Ludmila M. Mezhevikina et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
4 
Effects of Recombinant Leukemia Inhibitory 
Factor (LIF) on Functional Status of Mouse 
Embryonic Stem Cells 
Ludmila M. Mezhevikina1, Raushaniya R. Petrova1, 
Marina P. Borisova2, Olga Yu. Seraya2 and E.E. Fesenko1 
1Institute of Cell Biophysics Russian Academy of Sciences, 
Institutskaya 3, Pushchino, Moscow Region, 142290 
2Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, 
Institutskaya 3, Pushchino, Moscow Region, 142290 
Russia 
1. Introduction 
LIF (Leukemia Inhibitory Factor) protein isolated and characterized at early 1990 as a 
cytokine of the IL-6 family (Williams et al., 1988; Smith et al., 1988; Gearing et al., 1989) is 
now one of the most popular factors used for investigations with steam cells and embryos 
(Nagy et al., 1993; Thomson, Marshal, 1998; Metcalf, 2003; Gonzalez et al., 2004; Paling et al., 
2004; Ratajaczak et al., 2009), an a potential therapy for oncology and reproductive medicine 
(Kurek, 2000; Cheng et al., 2001; Gunawardana et al., 2003; Wobus, Boheler, 2005; Guney et 
al., 2008; Novatny et al., 2009; Aghajanova, 2010). Its molecular structure (amphiphilic 
protein composed mainly from hydrophobic positively charged amino acids) and molecular 
mechanism of its action are known in details today (Haines et al., 1999, 2000; Auernhammer, 
Melmed, 2000; Heinrich et al., 2003; Giese et al., 2005). As to current knowledge, LIF binds 
with LIF-receptor (LIF-R) of a plasma membrane and with gp130 glycoprotein, a 
transmembrane transporter causing activation of JAK/STAT3, MAPK and PI3P paths of 
intercellular transduction of a trigger signal (Hirano et al., 1997; Raz et al., 1999; 
Auernhammer, Melmed, 2000; Cheng et al., 2001; Park et al., 2003; Paling et al., 2004; 
Gonzalez et al., 2004; Boniani, Scholer, 2005). Targets genes activated by these signal systems 
response for proliferation, apoptosis, cell cycles and differentiation.  
Acting appropriate receptor complexes (LIF-R-gp130), LIF may cause various cell reactions. 
In mouse embryonic stem cells (ESC) it blocks processes of spontaneous differentiation and 
formation of embryoid bodies (EB, analogs of early mammal embryos) maintaining thus the 
stem cells in pluripotent state in vitro (Gearing et al., 1989; Raz et al., 1999; Nagy et al., 1993; 
Thomson, Marshal, 1998; Wobus, Boheler, 2005). High dependence of mouse ESC lines from 
LIF is evidenced by the fact that at a LIF-free culture medium the cells spontaneously 
differentiate into EB loosing thus their pluripotent properties. Main mechanisms of LIF 
effects, through cell membrane receptors, are comprehensively investigated (Haines et al., 
1999, 2000; Heinrich et al., 2003; Gonzalez et al., 2004; Giese et al., 2005) and widely 
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recognized; nevertheless dynamics of events at early stages of the protein interaction with 
ESC needs further clarifying. First, LIF is known to have three isoforms one of which (t-LIF) 
is not secreted but acts within a cell without contacting with outer-cell membrane receptors 
(Haines et al., 1999); second, mutant mouse ESC lines free of LIF-receptor complex proteins, 
LIFR and/or GP130, require presence of LIF in a culture medium (Ware et al., 1995; Li et al., 
1995; Yoshida et al., 1996; Dani et al., 1998; Boniani, Scholer, 2005). These facts tell some 
other (not receptor based) mechanisms of LIF mouse ESC regulation.  
Possibility of direct effects of recombinant LIF on properties of biological membranes is 
evidenced by our investigations with bilayer lipid membranes (Borisova et al., 2009), and 
membranes of intact cells highly dependent on the protein (Lobanok et al., 2008, 2009). We 
found that LIF acts as a membranotropic agent: it affects viscosity of membrane lipids, 
surface charge and conductivity of cell membranes. Basing these results, we supposed LIF-
mediated changes of cytoplasm membranes structure and functions to be related with 
maintenance of mouse ESC proliferative activity and pluripotent properties in vitro.  
2. Molecular mechanisms of LIF’s effects on cell membranes  
Possibility of non-receptor mechanism of stem cells LIF-regulation has been evidenced by 
studies with bilayer lipid membranes (BLM). We tried to answer the following questions: 1) 
what are effects of recombinant LIF proteins on a lipid bilayer and 2) whether mechanism of 
action varies according to a source of the protein origin (prokaryote or eukaryote). LIF is 
known to be produced in eukaryotic cells in a secrete form with 32-67 kDa molecular mass 
(Hilton et al., 1988; Haines et al., 2000; Heinrich et al., 2003); in bacterial cells recombinant 
LIF molecular masses are not higher than 20 kDa corresponding to theoretical estimations of 
LIF cDNA nucleotide sequence (Gearing et al., 1989; Hinds et al., 1998). Prokaryotic and 
eukaryotic LIFs have the same primary structures composed mainly by hydrophobic 
positively charged amino acids; differences between the recombinant proteins occur during 
post-translation events (Hinds et al., 1998; Hilton, Gough, 1998; Hirano et al., 2000). 
Our studies have demonstrated that eukaryotic LIF(eu) and prokaryotic LIF(pro) effect 
lipids of cell membranes in similar manner shifting their surface charge towards positive 
values (fig. 1). Sorption of recombinant LIF on a lipid bilayer depends on its concentration 
and pH of an external solution. рǻ 7.0 enhances LIF effects on a surface potential (fig. 1 Ǯ). 
At рǻ 6.0, effects of the same level need higher concentrations of the protein (fig. 1 ǯ). From 
fig.1 one can see that at use of 10 ng/ml and higher LIF, the potential jumps become less 
pH-dependent evidencing surface-active properties of the protein. From these data it 
emerges that recombinant LIF in concentrations used routinely for ESC cultivation sorbs at a 
surface of a lipid bilayer resulting in increase of the membrane positive charge. Calcium ions 
affect cell membranes in a similar way. 
Studies with BLM have shown that all used recombinant LIF proteins, regardless their 
origin, affect both surface potential (fig. 1) and conductivity of a lipid bilayer (fig. 2-4). A 
distinctive feature of LIF(pro) at its action on a lipid bilayer is spontaneous conductivity 
fluctuations without stationary state. At 100 mV, current through a lipid membrane changes 
chaotically and do not cause stable conductivity levels in a millisecond measurements range 
(fig.2, a); with S-shaped volt-ampere characteristics (fig. 2, b).  
Chaotic and non-regular character of productivity increase at presence of LIF(pro) is levelled 
at addition of 10мǺ ǿаCl2 into external solution. The observed changes of a lipid bilayer 
show dependence from presence of Ca2+. At that, bilayer conductivity is decreased and short 
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Fig. 1. Effect of mouse recombinant LIF protein from a prokaryotic expression system, 
LIF(pro), on a surface potential of a bilayer phosphatidylcholine membrane: Ǯ – рǻ 7.0, B – 
рǻ 6.0. 
 
 
 
Fig. 2. Current fluctuations (a) and current-voltage characteristics (b) of a lipid bilayer from 
phosphatidylcholine (20 mg/ml) in presence 2 ng/ml recombinant LIF(pro). External 
solution: 1Ǻ KCl, 10 мǺ CaCl2; 40 мǺ Tris-Hepes, рǻ 7.2; voltage 100 and -100 mV.  
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current disconnections vanish. No steady-state conductivity and moreover no relatively low 
rise of it could be approached at use of both LIF(eu) and LIF(pro), hence, effects of the 
proteins on a bilayer membrane may be evaluated only by quality characteristics of integral 
current change. 
A similar pattern is registered at BLM-testing of a potentially therapeutic protein LIF(eu) 
isolated from lif-transfected Cos-1 cells (Petrova et al., 2006). But in this case current 
increases by jumps of varying heights; such changes are usually registered when current 
passes through an ion channel (fig.3 a, current jumps 13.6, 2.4, 3.2 and 3.6 pA are pointed 
with arrows). Heights of current jumps in presence of LIF(eu) depend on ion strength of a 
external solution: the less is salt concentration the higher is current passing through the 
current-conducting unit. For example, in 0.1Ǻ KCl at 100 mV impressed voltage its mean is 
90±20 pA, in 0.2Ǻ KCl it is 22±6 pǮ and in 1Ǻ KCl it is 7±1 pǮ. A mean conductivity of a 
unit channel depends, besides, on a potential sign: at a negative value a mean amplitude of 
jumps is higher, than at a positive one (in 0.1Ǻ KCl - 175±19 pǮ and 1Ǻ KCl it is 90±20 pA 
versus 90 and 7 pA, respectively). Presented at fig. 3 b data show that in presence of LIF(eu) 
in 0.1Ǻ KCl solutions current depends linearly on voltage; in 0.2Ǻ KCl there is a 
hyperfunction under positive potential and overall current at 100 mV is almost twice greater 
than at -100 mV. In 1Ǻ KCl overall dependence of current has an opposite character but 
conductivity of the same channel also remains higher under a negative potential (fig. 4).  
The presented data tell that recombinant LIF proteins, regardless of a producer (prokaryote 
or eukaryote), affect a surface potential and conductivity of a lipid bilayer. LIF(eu) has an 
additional activity: affecting a BLM, it forms stable current-conducting structures, ion 
channels. Characteristics of current through the channels depend on value and sign of a 
membrane potential, ionic strength of a surrounding solution, and on a lipid composition of 
the bilayer. Secreted sequences (20 amino acid residues) which are activated at 
posttranslational modifications of mature protein may be responsible for formation of the 
ion channels (Petrova et al., 2006). Bacterial producers have no these systems, so we suppose 
LIF(pro) to lack channel-forming possibilities. Participation of glycated LIF(eu) sites in 
forming of current-conducting structures cannot be exempted either, though their function 
is considered to be stabilisation of molecules and their protection of photolytic degradation 
(Hinds et al., 1998; Hilton, Gough, 1998; Heinrich et al., 1998).  
Thus, electrophysiological studies show a possibility of direct effect of LIF recombinant 
molecules on lipid matrix of cell membranes involving not only LIF-receptor complex for pass 
of signals into cells. We suppose modification of cytoplasm membranes by ion-channels 
forming as one of the mechanisms of LIF regulatory action. This may play an important role in 
cell-cell interaction and metabolic cooperation of stem cells at their cultivation in vitro. 
3. Comparison of biological activity of LIF(eu) and LIF(pro) with mouse ESC 
cultures  
Recombinant LIF proteins from pro- and eukaryotic expression systems were tested on cells 
of R1 line, characterized by their dependence from feeder and LIF in a culture medium 
presence (Nagy et al., 1993). To prevent effects of feeder cells on ESC, R1 cells were 
cultivated on 0.1% gelatine cover. This way of cultivation resulted no reliable differences in 
performances of LIF(pro) and LIF(eu) effects on growth and renovation of R1 line cells were 
registered (table 1, fig. 5). During 48 h both proteins in 10-13 ng/ml concentrations 
maintained pluripotent properties of the cells and their relatively high rate of growth in 
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Fig. 3. Current jumps (0.1Ǻ KCl; 100 mV) (a) and integral current-voltage characteristics at 
different ionic strengths (b); 6.5 ng/ml LIF(eu); phosphatidilcholine membrane.  
 
 
Fig. 4. Current fluctuations at -100 and at 100 mV; phosphatidilcholine membrane (20 
mg/ml); 1Ǻ KCl; and 19.5 ng/ml LIF(eu).  
 
form of colonies without morphological signs of differentiation and EB formation (table 1, 
fig. 6 с). Correlation between differentiated and non-differentiated (pluripotent) colonies 
with high endogenous alkaline phosphatase (AP) activity was kept at a high level and did 
not depend on a source of LIF origin (fig. 5). At the absence of LIF: cell growth was 
inhibited; time of populations doubling increased (table 1) and EB were found in the 
medium pointing thus prevalence of embryonic differentiation processes over proliferation 
ones (fig. 5, fig. 6, д). 
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cell numbers (х105) Culture 
medium 48 h 72 h 
growth rate 
ESC population 
doubling time 
(h) 
LIF(eu) 2.0±0.52 3.4±0.85* 4.0±0.31* 13.6±2.4 
LIF(pro) 2.1±0.40 2.1±0.43 3.7±0.25* 13.2±2.7 
Control 
(LIF-free) 
1.1±0.20 1.2±0.80 2.4±0.17 22.2±6.3** 
Table 1. Comparative proliferative activity of R1 line mouse embryonic stem cells cultivated 
on 0.1 gelatine in presence of recombinant LIF(eu) and LIF(pro). Notice. Final concentration 
of LIF proteins in medium: 10-13 ng/ml. * - differences confidence (Ǿ≤0.05); **- differences 
confidence by time of cells populations doubling in LIF-supplemented and LIF-free media 
(Ǿ≤0.01).  
 
 
Fig. 5. Percentage of differentiated ( ) and non-differentiated ( ) colonies of R1 line 
embryonic cells cultivated on 0.1% gelatine in media with recombinant LIF proteins 
(10-13 ng/ml).  
Regulatory functions of LIF are apparently dose dependent (fig. 7); this was demonstrated 
by our experiments with techniques of R1 line cells cultivation on a feeder from mouse 
primary embryonic fibroblasts (PEF) and media supplemented with recombinant LIF 
protein in various concentrations. These cultivation conditions enhance the general 
tendency of pluripotent cells: development by colonies without visible signs of spontaneous 
differentiation and formation of EB. It is well known, that cells of mouse PEF can produce 
their own LIF (Williams et al., 1988) and can additionally saturate a nutrient medium with 
this factor. But in spite of such a possibility, use of recombinant LIF in small concentrations 
(2.5-5.0 ng/ml) and of feeder cultivation does not provide a pluripotent status of R1 line 
cells in culture completely (fig. 7). To 48 h number of damaged cells in populations with low  
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Fig. 6. Morphology of colonies of R1 line embryonic stem cells in a medium with 
recombinant LIF(pro) after 48 h cultivation on PEF feeder (а) and on 0.1% gelatine (с); 
detecting of alkaline phosphatase activity (b), embryoid body in a LIF-free medium (d).  
 
 
Fig. 7. Dependence of formation of non-differentiated pluripotent colonies of R1 embryonic 
stem cells from LIF(pro) concentration in 24 (1) and 48 h (2) of PEF feeder cultivation.  
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content of exogenous LIF protein is increased; rate of cell divisions is inhibited and EB occur 
(table 2). We registered such a situation at growing of R1 cells on a gelatine support in a LIF-
free medium (table 1, fig. 5, 6 д). 
 
Cell number (х105) LIF 
concentration 
(ng/ml) 48 h 72 h 
Growth 
rate 
Population 
doubling time 
(h) 
N/D (%) 
5 19.7±1.2 27.7±1.4 3.9±0.2 12.2±0.9 42.75 
10 21.3±0.7* 34.0±1.1* 4.3±0.2 10.0±0,5** 67.45 
20 34.3±1.8* 32.3±1.5* 6.9±0.3* 7.0±0.7** 82.90 
Control (LIF-
free) 
15.6±3.1 19.0±8.0 3.1±0.6 15.0±1.8 33.70 
Table 2. Proliferative activity and growth of R1 embryonic stem cells colonies in dependence 
on recombinant LIF(pro) concentration at cultivation on PEF feeder. Notice. N/D - non-
differentiated pluripotent colonies of embryonic stem cells with high activity of endogenous 
alkaline phosphatase; * - reliable increase of proliferative activity and rate of colonies growth 
under effect of 10-20 ng/ml of LIF (Ǿ≤0.05); ** - reliability of differences of cell populations 
doubling time in media with 10-20 ng/ml LIF and without LIF (Ǿ≤0.01). 
Stem cells of R1 line require relatively high concentrations of recombinant LIF in a culture 
medium (10-20 ng/ml) that decreases their doubling times up to 10 hours in average and 
increases rate of their growth 1.5-2.0 folds relatively cells developing in a LIF-free medium 
(table 1, 2). At different conditions of R1 cultivation (gelatine or PEF feeder), in the presence 
of LIF in optimal concentrations, approximately the same share (70-80%) of pluripotent 
colonies can be registered (fig. 5, table 2). Hence, we may postulate that LIF(pro) and LIF(eu) 
are equally effective in their support of ESC pluripotency and high proliferative activity in 
vitro. Our observations tell that only R1 stem cells with active proliferation keep their 
pluripotent potential in the presence recombinant LIF.  
4. Effects on cell death (apoptosis) and cell cycles  
When cell differentiation is difficult, correlation of two forms of stem cells response, 
proliferation/cell death, may serve as an essential parameter of their reaction on effects of 
regulatory LIF protein and reflect self-renewal potential of population. For example, our 
investigations showed that 5-10 ng/ml concentrations of LIF decrease share of apoptotic 
cells in R1 population to 2.0% in comparison with 7.2 % following 18 hours of incubation in 
LIF-free medium (Lobanok et al., 2008, 2009). At 5 ng/ml concentration LIF is more effective 
as anti-apoptotic agent than at 10 ng/ml. It may be caused by that apoptosis is an active 
form of cell reaction not only on unfavourable conditions, like deficiency of growth factors 
in cultivation medium but on their physiological concentrations activating cell growth. In 
case of R1 ESC this concentration is 10-20 ng/ml LIF (table 1 and 2, fig. 7).  
Another essential characteristic of mouse ESC response on effect of LIF regulatory molecules 
reflecting potential of the cells for renovation and reproduction is distribution of cells by 
phases of cell cycle. Presented histograms: G1 (content of 2C DNA), S (from 2 to 4ǿ) and 
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G2+M (4C) tell that if presence 5 and 10 ng/ml of recombinant LIF(pro) presents in a 
medium, share of R1 cells in S-phase of cell-cycle decreases (fig. 8). A specific feature of 
mouse ESC lines worth mentioning: their cells spend the most part of their life-time in S-
phase, during which DNA synthesis occurs. Contrary to somatic cells of tissue culture, ESC 
do not need external stimuli to initiate DNA replication processes (Smith, 2001). It can 
explain why ESC are hardly moved out from cell cycle into G1 or G0 stages. 
 
 
Fig. 8. Effect of recombinant LIF(pro) concentration on distribution of R1 mouse embryonic 
stem cells by phases of a cell cycle after 18 h cultivation on PEF feeder. 1) Control (LIF-free), 
2)  5 and 3) 10 ng/ml LIF in culture medium. 
Nevertheless, from fig. 8 one can see that LIF in 10 ng/ml concentration, optimal for ESC, 
activates these processes. In growing populations of R1 after 18 hours of incubation with 10 
ng/ml LIF(pro) share of stem cells in G1 phase increases in comparison with cells that did 
not get the protein or got it in a smaller concentration (fig. 8). Increase of G1-phase cells 
number may tell about their spontaneous differentiation into EB and about enhanced 
production of D-cyclins inhibiting cell division (Savatier et al., 1996). But we must keep in 
mind that too short G1 period is typical for ESC and therefore mechanisms of their 
activation may differ somewhat from those of somatic cells (Savatier et al., 1996; Rohwedel 
et al., 1996; Wianny et al., 1998). For example, some part of mouse ESC keep their ability to 
differentiate into EB and to grow by colonies in LIF-free medium, but rates of their division 
become shorter in comparison with growing with LIF (table 1 and 2, fig. 5).  
ESC, being cultivated, may stop at one of the cell cycle stages, therefore increase of their 
number in S synthetic phase does not always reflect proliferative activity of population in 
whole; this is exemplified by fig. 8. In this connection, we calculated rate of cells in S phase 
share to G2+M as S/(G2+M). The calculations shows that after 18 hours of incubation in a 
LIF-free medium the most part of R1 cells (more than 70 %) are in S phase and S/(G2+M) 
equation reflecting proliferative potential of a culture equals to 10.9. Affected by 5 ng/ml of 
LIF, the parameter decreases to 4.7, whereas 10 ng/ml decreases it only to 8.3. It may be 
provided by the following: in presence of 10 ng/ml LIF, mouse ESC pass an S-phase more 
rapidly and about 10 % of cells stop at a G1 restriction point (fig. 8). Small doses of LIF 
effects exit of cells from S-phase, increasing thus a proliferative index of a population and 
share of cells with DNA content ≥2ǿ. 
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5. Conclusion  
Thus comparative analysis of recombinant mouse LIF from pro- and eukaryotic expression 
systems made in the investigation with bilayer lipid membranes and cultures of ESC (R1 
line) showed that both protein types, LIF(pro) and LIF(eu), have membranotropic effects. 
Independently on an expression system, molecules of recombinant LIF are incorporated into 
lipid bilayer, causing increase of surface potential and membrane electric conductivity. LIF-
induced changes of lipid matrix of cell membranes may play a key role in maintenance of 
pluripotent properties of mouse ESC in vitro. We suppose binary mechanism of LIF actions 
on both receptors (LIF-R and gp130) and lipid matrix of cell membranes to underlie its 
functional redundancy. For example, our investigations show that recombinant mouse LIF 
affects ESC proliferation, apoptosis and cells distribution by cell cycle phases (decreases 
S/(G2+Ǻ) ratio of a cell cycle and time of ESC population doubling). 
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